Renal Cancer - Results from #5720

Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study May 19, 2016

ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells May 18, 2016

The role of micronutrients in the risk of urinary tract cancer May 18, 2016

Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma May 18, 2016

Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan May 17, 2016

Metastatic renal cell carcinoma: The first report of unilateral fundus hemorrhage induced by sorafenib May 17, 2016

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma May 16, 2016

Heterogeneous vascular patterns in renal cell carcinomas May 15, 2016

Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study May 15, 2016

ASCO Plenary Sessions: impact, legacy, future May 15, 2016

Risk of Renal Cell Carcinoma among Kidney Transplant Recipients in the United States May 13, 2016

Results of Therapy for Wilms Tumor and Other Malignant Kidney Tumors: A Report From the Chilean Pediatric National Cancer Program (PINDA) May 12, 2016

Sunitinib in metastatic renal cell carcinoma: Experience from single center study, efficacy and safety May 11, 2016

The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease May 10, 2016

A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC) May 10, 2016

Diagnostic accuracy of pre-operative imaging findings in presumed clinical T1a renal cell carcinomas May 9, 2016

Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma May 9, 2016

Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor May 9, 2016

Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) May 9, 2016

The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma May 5, 2016

Page 287 of 457